These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 17159598

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
    Mladosievicova B, Carter A, Kristova V.
    Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Pharmacogenomics: the quest for individualized therapy].
    López-López M, Guerrero-Camacho JL, Familiar-López IM, Jung-Cook H, Corona-Vázquez T, Alonso-Vilatela ME.
    Rev Neurol; 2007; 39(11):1063-71. PubMed ID: 15597270
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Pharmacogenomics: the inherited basis for interindividual differences in drug response.
    Evans WE, Johnson JA.
    Annu Rev Genomics Hum Genet; 2001; 2():9-39. PubMed ID: 11701642
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Role of pharmacogenetics in variable response to drugs: focus on opioids.
    Kadiev E, Patel V, Rad P, Thankachan L, Tram A, Weinlein M, Woodfin K, Raffa RB, Nagar S.
    Expert Opin Drug Metab Toxicol; 2008 Jan; 4(1):77-91. PubMed ID: 18370860
    [Abstract] [Full Text] [Related]

  • 54. [Pharmacogenetics in oncology].
    Morán González D, Jiménez Cabrera S, Domínguez-Gil Hurlé A.
    Med Clin (Barc); 2008 Jul 05; 131(5):184-95. PubMed ID: 18674490
    [Abstract] [Full Text] [Related]

  • 55. Pharmacogenomics of cancer chemotherapy-induced toxicity.
    Miller CR, McLeod HL.
    J Support Oncol; 2007 Jan 05; 5(1):9-14. PubMed ID: 17265780
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel.
    Bosch TM, Huitema AD, Doodeman VD, Jansen R, Witteveen E, Smit WM, Jansen RL, van Herpen CM, Soesan M, Beijnen JH, Schellens JH.
    Clin Cancer Res; 2006 Oct 01; 12(19):5786-93. PubMed ID: 17020985
    [Abstract] [Full Text] [Related]

  • 58. Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing.
    Kacevska M, Robertson GR, Clarke SJ, Liddle C.
    Expert Opin Drug Metab Toxicol; 2008 Feb 01; 4(2):137-49. PubMed ID: 18248309
    [Abstract] [Full Text] [Related]

  • 59. Part 3: Pharmacogenetic variability in phase II anticancer drug metabolism.
    Deenen MJ, Cats A, Beijnen JH, Schellens JH.
    Oncologist; 2011 Feb 01; 16(7):992-1005. PubMed ID: 21659608
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.